{"id":"W7135052041","doi":"10.1183/13993003/erj.38.suppl_55.p867","title":"NVA237 once daily improves dyspnea and health-related quality of life (HRQoL) in patients with COPD: The GLOW1 trial","year":2011,"lang":"en","type":"article","venue":"European Respiratory Journal","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Minimal clinically important difference; COPD; Quality of life (healthcare); Muscarinic antagonist; Placebo; Inhaler; Dry-powder inhaler","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008411786,0.0008162958,0.001787132,0.0001812476,0.0002067144,0.0008980155,0.0006524866,0.001052361,0.004296185],"category_scores_gemma":[0.0005207058,0.0002216249,0.001175682,0.0001832121,0.0004744009,0.0003721407,0.000314369,0.001448964,0.0006852885],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004380658,"about_ca_system_score_gemma":0.0005907017,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000718142,"about_ca_topic_score_gemma":0.001887673,"domain_scores_codex":[0.9997107,0.0001534781,0.00001590475,0.00004387484,0.00002932018,0.00004677597],"domain_scores_gemma":[0.9997007,0.00005915555,0.0000930305,0.00001958057,0.00001600746,0.0001115825],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8758929,0.004816806,0.006062238,0.00352316,0.004040777,0.0001701063,0.0001047755,0.00101707,0.009265645,0.0003399599,0.006745698,0.08802088],"study_design_scores_gemma":[0.857355,0.1006208,0.03241514,0.0004362496,0.002622625,0.0002920407,0.0001093078,0.0008370802,0.001419413,0.0004520194,0.003383704,0.00005657616],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9743416,0.02091473,0.0001062348,0.00108095,0.0001814328,0.0004248167,0.001201933,0.0000578447,0.001690377],"genre_scores_gemma":[0.986552,0.006645528,0.0003093307,0.001048823,0.0002824353,0.0008538514,0.001370216,0.00001362164,0.002924197],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004296185,"threshold_uncertainty_score":0.01437217,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07454640088819758,"score_gpt":0.31320630369925,"score_spread":0.2386599028110524,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}